Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
NCT05881447
Albuminuria, Anemia
Bagamoyo, Coast Region, Tanzania
View Trial DetailsNCT Number: NCT04160533
The problem of the quality of primary health care medical system for patients with arterial hypertension is acute for the investigator's country, as these diseases are the most common and cause the high mortality of the population.
The concept of "quality of primary health care medical system" includes its timeliness, accessibility and provision of medical care to the patient at the modern level, which is determined by the degree of performance by doctors of medical and diagnostic measures corresponding current clinical recommendations.
The system of cardiovascular desease registries, established in the Federal State Clinical Hospital of the Russian Federation Ministry of Public Health with the automated analysis of data on examination and treatment, in comparison with clinical Recommendations. It makes possibility to identify shortcomings and develop approaches to improving the provision of medical care to patients in real clinical practice.
Comparative analysis of the quality of examination and treatment in different samples of patients with cardiovascular desease, observed in 2018-2020, compared with results of previous years will identify ptrends in the provision of medical care to patients with cardiovascular desease.
Interested in participating?
Request Info18 year–99 year
All sexes
Observational
Federal State Budgetary Institution "National Medical Research Center of Cardiology named after academician E.I. Chazov" of the Ministry of Healthcare of the Russian Federation, Moscow, Moscow Oblast, Russia
The study will be conducted using the arterial hypertension registry method, which is a computer program with remote access that allows online collection medical data from medical primary care system. To minimize operator errors, doctors was trained before the work with the arterial hypertension registry. User's guide was developed and the rights of users was determined. Data of examination and treatment of patients from 18 years and older with an established diagnosis of hypertension will be added from outpatient cards into the registry of the arterial hypertension. The information is received by the Institution in an impersonal form through a certified dedicated security channel. Patients sign an informed consent for entering their medical data into the registry of arterial hypertension
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The diagnosis of arterial hypertension -
Exclusion criteria
No diagnosis of arterial hypertension
-
Time frame: 2018 - 2021 years
The level of systolic and diastolic blood pressure measured according to the rules described in the clinical guidelines for the treatment and diagnosis of arterial hypertension of the European Society of Cardiology during the visit (mmHg) is entered into the database by doctors.
Time frame: 2018-2021
Diagnosis data is entered by doctors as a "yes" or "no" category.
Time frame: 2018-2021
Antihypertensive drugs the patient takes are entered into the database. Drugs are analyzed by groups and daily dosages
Contact information is provided by the study sponsor or research team.
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Other Gov
Registry of Arterial Hypertension: "Study of Modern Phenotypes of Arterial Hypertension, Including Secondary Forms, in Order to Create Personalized Methods of Treatment"
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05881447
Albuminuria, Anemia
Bagamoyo, Coast Region, Tanzania
View Trial DetailsNCT06169241
Arterial Hypertension, Cardiovascular Diseases
Rio de Janeiro, Brazil
View Trial DetailsNCT06769269
Arterial Hypertension, Cardiovascular Diseases
Meknes, Morocco
View Trial DetailsNCT06722625
Arterial Hypertension, Cardiovascular Diseases
Poznan, Poland
View Trial Details